20 results
·
28ms
·
Sources: EU EUDAMED, US FDA
LP-60 LOW PRESSURE INFLATION DEVICE
FDA 510(k)
FDA Class 2
·Cardiovascular
REVELATION DIAMOND
FDA UDI
Ss White Burs, Inc.·D6909102052·REVELATION DIAMOND 830-010C - 5 PACK
DeRoyal
FDA UDI
DEROYAL INDUSTRIES, INC.·00749756350006·ENT MINOR PACK
DeRoyal
FDA UDI
DEROYAL INDUSTRIES, INC.·00749756019170·WRIST AND FOREARM
Novo Surgical
FDA UDI
NOVO SURGICAL, INC.·00842331120572·endoscopic clip applier, not rotatable, for lar...
H.A.M., 05-Channel w/ blank insert holes
FDA UDI
MICK RADIO NUCLEAR INSTRUMENT, INC·00817330024558·
Gen. Acces/ Instr. Tip Guard
FDA UDI
KATENA PRODUCTS, INC.·00841668112267·SURG-I-BAND ORANGE
H.A.M.,05-Chan w blank insert holes,Slot
FDA UDI
MICK RADIO NUCLEAR INSTRUMENT, INC·00817330024565·
Reicodent
FDA UDI
devemed GmbH·04061644050376·BASIC CLIP Wash Tray (271,5x177,5x33,0mm)
empty
Grasping forceps
FDA UDI
SOPRO-COMEG GmbH·04059082022161·
AAIO-7, AAIO WIRLESS
FDA 510(k)
FDA Class 2
·Ophthalmic
HemoSphere Advanced Monitor, HemoSphere Tissue Oximetry Module
FDA 510(k)
FDA Class 2
·Cardiovascular
GMK-SPHERE TIBIAL INSERT FIXED SPHERE FLEX SIZE 5/11 MM R
FDA Adverse Event
Injury
·MEDACTA INTERNATIONAL SA·Product code JWH·March 5, 2021
CADD ADMINISTRATION SET
FDA Adverse Event
Malfunction
·SMITHS MEDICAL MD, INC·Product code FPA·July 22, 2024
GMK-SPHERE TIBIAL INSERT FIXED SPHERE FLEX #SIZE 5/11 MM R
FDA Adverse Event
Injury
·MEDACTA INTERNATIONAL SA·Product code JWH·July 20, 2023
3 GANG 1O2¿ MANIFOLD W/CHECK VALVE, ROTATING LUER, APPX 1.2ML
FDA Adverse Event
Malfunction
·ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V.·Product code FPA·October 6, 2023
33MM HEMORRHOID STAPLER 4.8MM STAPLES
FDA Adverse Event
Injury
·UNITED STATES SURGICAL·Product code GDW·November 22, 2010
PORTABLE AIR COMPRESSOR FOR MEDICAL PURPOSES
FDA Adverse Event
EMG TECHNOLOGY CO. LTD·Product code BTI·July 2, 2014
PARKER BATH
FDA Adverse Event
Malfunction
·ARJO HOSPITAL EQUIPMENT AB·Product code ILJ·November 23, 2012
VNS Therapy¿ AspireHC¿ Generator, VNS Therapy¿ AspireSR¿ Generator. Model No. 105. Product Usage: United States Indications for Use: Epilepsy (PMA 970003): The VNS Therapy System is indicated for use as an adjunctive therapy in reducing the frequency of seizures in adults and adolescents over 12 years of age with partial onset seizures that are refractory to antiepileptic medications. Depression (PMA 970003/S050): VNS Therapy is indicated for the adjunctive long-term treatment of chronic or recurrent depression for patients 18 years of age or older who are experiencing a major depressive episode and have not had an adequate response to four or more adequate antidepressant treatments. Indications outside the U.S.: Epilepsy (Non-US): The VNS Therapy System is indicated for use as an adjunctive therapy in reducing the frequency of seizures in patients whose epileptic disorder is dominated by partial seizure (with or without secondary generalization) or generalized seizures that are refractory to antiepileptic medications. AspireSR (Seizure Response) features the Automatic Stimulation Mode which is intended for patients who experience seizures that are associated with cardiac rhythm increases known as ictal tachycardia. Depression (Non-US): The VNS Therapy System is indicated for the treatment of chronic or recurrent depression in patients who are experiencing a treatment-resistant or treatment-intolerant depressive episode.
FDA Enforcement
Class II
·Terminated·Cyberonics, Inc·August 23, 2017